Loss of E-cadherin and P-cadherin, and gain of N-cadherin (neuronal), known as cadherin switching [46], facilitates melanoma cell metastasis and is associated with worse prognosis of SKCM [48]. This evidence concerns the gene CDH17 and melanoma.